Search images on Google Product Monograph
Active Ingredients:
- trastuzumab deruxtecan, 100 MG/VIAL
DIN: 02514400
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: ASTRAZENECA CANADA INC – official site
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FD - (ATC, WHO)
- L01FD04 - TRASTUZUMAB DERUXTECAN (WHO)
External Links for Enhertu:
Search on Google
- Enhertu side effects
- Enhertu dosage
- trastuzumab deruxtecan side effects
- trastuzumab deruxtecan dosage
Astrazeneca Canada Inc
Go to AstraZeneca website to see drug product details. Sometimes you can find enhertu photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.